Eli Lilly and Company Stock News
$915.04
1.11%
yesterday
NYSE,
Sep 19, 10:14 pm CET
Eli Lilly and Company Stock News
Positive
24/7 Wall Street
●
19 days ago
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive.
Positive
The Motley Fool
●
19 days ago
These businesses are capitalizing on the future of their respective industries. Eli Lilly is already experiencing untold success amid the GLP-1 inhibitor drug boom, but the nearly 150-year-old company has plenty of growth drivers to rely on.
Neutral
24/7 Wall Street
●
20 days ago
Remember when a stock becoming valued at $1 trillion was a big thing?
Neutral
Investors Business Daily
●
20 days ago
Meta, Costco and Eli Lilly along with two others are trading near buy points coming out of a week marked by Nvidia earnings.
Positive
The Motley Fool
●
20 days ago
Eli Lilly is a growth machine that never runs out of opportunities. Novo Nordisk is still gaining momentum.
Positive
The Motley Fool
●
20 days ago
Eli Lilly and Novo Nordisk compete in a handful of different markets. Novo Nordisk is scaling up its output and upgrading its medicines a bit more slowly.
Positive
The Motley Fool
●
20 days ago
Healthcare and pet spending continue to perform in a wide range of economic environments. Eli Lilly is a storied business, raking in cash and profits while paving the way to a stronger future.
Positive
Market Watch
●
20 days ago
Kellanova led the list after accepting a takeout offer from Mars, while Starbucks might have been the month's biggest positive surprise.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
